Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of Type 2 Diabetic Kidney Disease in 2022: A Narrative Review for Specialists and Primary Care
David Z.I. Cherney, Alan Bell, Louis Girard, et al.
Canadian Journal of Kidney Health and Disease (2023) Vol. 10
Open Access | Times Cited: 10

Showing 10 citing articles:

Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis
Eneyew Talie Fenta, Habitu Birhan Eshetu, Natnael Kebede, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity
Mohammad Kazempour-Dizaji, Somayeh Mojtabavi, Arash Sadri, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106709-106709
Closed Access | Times Cited: 17
Optimizing Prescribing for Individuals With Type 2 Diabetes and Chronic Kidney Disease Through the Development and Validation of Algorithms for Community Pharmacists
Jennifer Morris, Marisa Battistella, Karthik Tennankore, et al.
Canadian Journal of Kidney Health and Disease (2025) Vol. 12
Open Access
Analysis of the global burden of CKD-T2DM in young and middle-aged adults in 204 countries and territories from 2000 to 2019: A systematic study of the global burden of disease in 2019
Beiyan Liu, Linfeng Li, Huanxi Cui, et al.
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111884-111884
Closed Access | Times Cited: 3
Cardiometabolic Care: Assessing Patients with Diabetes Mellitus with No Overt Cardiovascular Disease in the Light of Heart Failure Development Risk
Christina Chrysohoou, Christos Fragoulis, Ioannis Leontsinis, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1384-1384
Open Access | Times Cited: 4
Clinical Recommendations for Managing Genitourinary Adverse Effects in Patients Treated with SGLT-2 Inhibitors: A Multidisciplinary Expert Consensus
Juan José Gorgojo Martínez, José Luis Górriz, Ana María Cebrián Cuenca, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6509-6509
Open Access | Times Cited: 1
Review of the top nephrology studies of 2020-2023
Jo‐Anne Wilson, Jennifer Pitman, Judith Marin, et al.
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (2024) Vol. 157, Iss. 4, pp. 174-180
Open Access
Optimizing Finerenone in People With Diabetes and Chronic Kidney Disease: An Opportunity for the Pharmacist
Jennifer D. Goldman
Journal of Pharmacy Practice (2024) Vol. 37, Iss. 6, pp. 1374-1379
Open Access
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists
Anjay Rastogi, Ashté Collins, Ellie Kelepouris, et al.
Journal of Primary Care & Community Health (2024) Vol. 15
Open Access
Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus
Louis Girard
Canadian Diabetes & Endocrinology Today (2024)
Closed Access
Page 1

Scroll to top